Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vonoprazan vs Rabeprazole in Bismuth Quadruple Therapy for H. pylori
NCT07165444Recruiting
- Sponsor
- Tanta University
- Start
- Sep 2025
- Primary completion
- Feb 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of vonoprazan in Helicobacter pylori infection (2 arms), sponsored by Tanta University. Primary endpoint: Helicobacter pylori eradication. Started Sep 2025; status: recruiting.
02
Drugs
vonoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07165444.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07165444.